Article
Cardiac & Cardiovascular Systems
Katharina Doerr, Michael Kammer, Roman Reindl-Schwaighofer, Matthias Lorenz, Thomas Prikoszovich, Rodrig Marculescu, Dietrich Beitzke, Alice Wielandner, Reinhold G. Erben, Rainer Oberbauer
Summary: The study aimed to investigate the effect of FGF23 suppression by calcimimetic therapy on LVH progression in patients with chronic kidney disease. The results showed that etelcalcetide treatment inhibited the progression of LVH compared to alfacalcidol, potentially reducing the risk of sudden cardiac death in this population.
CIRCULATION RESEARCH
(2021)
Article
Urology & Nephrology
Laura M. Dember, Adriana Hung, Rajnish Mehrotra, Jesse Y. Hsu, Dominic S. Raj, David M. Charytan, Finnian R. Mc Causland, Renu Regunathan-Shenk, J. Richard Landis, Paul L. Kimmel, Alan S. Kliger, Jonathan Himmelfarb, T. Alp Ikizler
Summary: Chronic inflammation is common among hemodialysis patients, and the use of anti-cytokine therapy to inhibit inflammation in this population has been proposed but not well studied. This pilot trial evaluated the safety, tolerability, and feasibility of an IL-1 receptor antagonist, anakinra, in hemodialysis patients. The study found that anakinra was well tolerated and did not increase the risk of infections or cytopenias. However, its efficacy in reducing HsCRP was not significant. The promising safety data and potential efficacy on CRP and IL-6 support the need for definitive trials of IL-1 inhibition in improving outcomes in hemodialysis patients.
KIDNEY INTERNATIONAL
(2022)
Article
Urology & Nephrology
Kathleen M. Hill Gallant, Elizabeth R. Stremke, Laurie L. Trevino, Ranjani N. Moorthi, Simit Doshi, Meryl E. Wastney, Nozomi Hisada, Jotaro Sato, Yoshitaka Ogita, Naohisa Fujii, Yuya Matsuda, Takei Kake, Sharon M. Moe
Summary: The study evaluated the safety and efficacy of EOS789, a novel paninhibitor of phosphate transport, in patients receiving intermittent hemodialysis therapy. While the drug was shown to be safe and well tolerated, its effectiveness in inhibiting phosphate absorption was not significantly different from placebo or when used in combination with sevelamer. Further studies are needed to evaluate the effectiveness of EOS789 in future trials.
KIDNEY INTERNATIONAL
(2021)
Article
Urology & Nephrology
Wan-Chuan Tsai, Hon-Yen Wu, Yen-Ling Chiu, Ju-Yeh Yang, Mei-Fen Pai, Yong-Ru Wu, Wan-Yu Lin, Kuan-Yu Hung, Kuo-Liong Chien, Shih-Ping Hsu, Yu-Sen Peng
Summary: The study found that increased dietary phosphorus intake rapidly increases serum phosphate, iPTH, and iFGF23 levels, and decreases serum calcium levels, highlighting the important role of daily fluctuations in dietary habits in disturbed mineral homeostasis in hemodialysis patients.
Article
Medicine, General & Internal
Teresa A. Hillier, Kathryn L. Pedula, Keith K. Ogasawara, Kimberly K. Vesco, Caryn E. S. Oshiro, Suzanne L. Lubarsky, Jan Van Marter
Summary: In this study comparing one-step screening with two-step screening for gestational diabetes mellitus, the one-step approach resulted in more diagnoses of gestational diabetes mellitus but did not have a significant impact on the incidence of adverse perinatal and maternal outcomes.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Sean D. Pokorney, Glenn M. Chertow, Hussein R. Al-Khalidi, Dianne Gallup, Pat Dignacco, Kurt Mussina, Nisha Bansal, Crystal A. Gadegbeku, David A. Garcia, Samira Garonzik, Renato D. Lopes, Kenneth W. Mahaffey, Kelly Matsuda, John P. Middleton, Jennifer A. Rymer, George H. Sands, Ravi Thadhani, Kevin L. Thomas, Jeffrey B. Washam, Wolfgang C. Winkelmayer, Christopher B. Granger
Summary: This study evaluated the safety and efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and atrial fibrillation. The trial showed no significant difference in major or clinically relevant nonmajor bleeding between apixaban and warfarin, and there was overlap in apixaban blood concentration between patients with and without bleeding events. Future randomized studies are needed to assess the risks and benefits of anticoagulation in this population.
Article
Urology & Nephrology
Jinmei Yin, Jun Yin, Rongli Lian, Peiqiu Li, Jing Zheng
Summary: This study aims to analyze the effectiveness of an education program focusing on phosphate control among hemodialysis patients. The results showed significant improvements in controlled serum phosphorus, knowledge of hyperphosphatemia, and adherence to phosphate binders, indicating the program's success in enhancing patients' adherence to phosphorus control.
Article
Biochemistry & Molecular Biology
Arpita Basu, Kenneth Izuora, Andrew Hooyman, Hal R. R. Scofield, Jeffrey L. L. Ebersole
Summary: Clinical trials have shown that dietary strawberries can improve cardiometabolic risks. However, no previous studies have examined the effects of strawberries on serum metabolomic profiles. This study demonstrated that dietary supplementation of strawberries significantly improves the serum metabolic profiles of cardiometabolic risks in adults.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Surgery
Dirk P. A. Versteegden, Magaly J. J. Van Himbeeck, Misha D. Luyer, Gust van Montfort, Jean-Paul J. G. M. de Zoete, Johannes Franciscus Smulders, Simon W. Nienhuijs
Summary: This randomized controlled trial evaluated the value of an eHealth platform and self-monitoring devices as additions to standard bariatric care. The results showed that participation in the eHealth intervention had no significant impact on clinical outcomes.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Article
Medicine, General & Internal
Hiroaki Ogata, Masafumi Fukagawa, Hideki Hirakata, Tatsuo Kagimura, Masanori Fukushima, Tadao Akizawa
Summary: This open-label randomized clinical trial found that adding calcium-based phosphate binders did not significantly reduce cardiovascular events compared with lanthanum carbonate-based treatment alone in patients with hyperphosphatemia undergoing hemodialysis. The study suggests that non-calcium-based phosphate binders may not be more effective than calcium-based binders in reducing cardiovascular events among these patients.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Biochemistry & Molecular Biology
Luona Wen, Chunrong Tang, Yun Liu, Jie Jiang, Dee Zou, Wenxuan Chen, Shilin Xu, Yuqi Wang, Jingxian Qiu, Xiaoshi Zhong, Yan Liu, Rongshao Tan
Summary: This study found that non-protein calorie supplements may improve the nutritional status of MHD patients with PEW, including increasing subjective global assessment scores, reducing the proportion of PEW patients, improving body mass index, nutrition risk screening 2002 scores, mid-upper arm circumference, and mid-arm muscle circumference.
Article
Nutrition & Dietetics
Amanda dos Santos Moraes, Ricardo da Costa Padovani, Caue Vazquez La Scala Teixeira, Maria Gabriela Soria Cuesta, Silvandro dos Santos Gil, Barbara de Paula, Gilberto Monteiro dos Santos, Rodrigo Tributino Goncalves, Ana Raimunda Damaso, Lila Missae Oyama, Ricardo Jose Gomes, Danielle Arisa Caranti
Summary: The study aimed to compare the effects of three different long-term treatments on adults with obesity. Results showed that the interdisciplinary therapy plus cognitive behavioral therapy group had the most significant improvements in anthropometric profiles, quality of life, eating behaviors, and depression levels compared to the physical exercise group and education and health group.
FRONTIERS IN NUTRITION
(2021)
Article
Urology & Nephrology
Markus Ketteler, Andrzej Wiecek, Alexander R. Rosenkranz, Andreas Pasch, Jan Rekowski, Burkhard Hellmann, Michael Karus, Richard Ammer
Summary: The study confirmed that combined treatment of modified release nicotinamide (NAMR) with oral phosphate binders significantly improved phosphate control in hemodialysis patients, with superior effects compared to placebo, and also resulted in lower intact parathyroid hormone levels and improved calcification propensity. However, the NAMR group experienced more frequent side effects such as diarrhea and pruritus.
KIDNEY INTERNATIONAL REPORTS
(2021)
Article
Urology & Nephrology
Luigi Morrone, Suetonia C. Palmer, Valeria M. Saglimbene, Annalisa Perna, Giuseppe Cianciolo, Domenico Russo, Loreto Gesualdo, Patrizia Natale, Antonio Santoro, Sandro Mazzaferro, Mario Cozzolino, Adamasco Cupisti, Marina Di Luca, Biagio Di Iorio, Giovanni F. M. Strippoli
Summary: This study found that calcifediol supplementation for patients undergoing hemodialysis with vitamin D insufficiency did not have definitive effects on reducing mortality and cardiovascular outcomes.
JOURNAL OF NEPHROLOGY
(2022)
Article
Urology & Nephrology
Ping Zhang, Shilong Xiang, Bicheng Liu, Xiaohui Wang, Xiaoping Yang, Chaoyang Ye, Zunsong Wang, Yanlin Li, Li Zhou, Caili Wang, Hongbo Li, Jian Huang, Ai Peng, Xiaoping Wang, Deguang Wang, Jie Xiao, Wenli Chen, Hong Cheng, Nan Mao, Jianqin Wang, Lin Yang, Jianghua Chen
Summary: This study aimed to evaluate the efficacy and safety of nalfurafine in treating refractory CKD-aP in Chinese patients. The results showed that nalfurafine effectively reduced itching and had low incidence of adverse drug reactions.
Review
Immunology
Dominic Mudiayi, Soroush Shojai, Ikechi Okpechi, Emily A. Christie, Kevin Wen, Mostafa Kamaleldin, Mohamed Elsadig Osman, Meaghan Lunney, Bhanu Prasad, Mohamed A. Osman, Feng Ye, Maryam Khan, Htay Htay, Fergus Caskey, Kailash K. Jindal, Scott Klarenback, Vivekanand Jha, Eric Rondeau, Rumeyza Turan Kazancioglu, Shahrzad Ossareh, Kitty J. Jager, Csaba P. Kovesdy, Philip J. O'Connell, Elmi Muller, Timothy Olanrewaju, John S. Gill, Marcello Tonelli, David C. Harris, Adeera Levin, David W. Johnson, Aminu K. Bello
Summary: This study explores the availability, accessibility, and quality of kidney transplantation (KT) across countries and regions. The results demonstrate significant disparities in KT incidence, prevalence, availability, accessibility, and quality worldwide, with lower rates observed in low- and lower-middle income countries. Understanding these differences will inform efforts to improve awareness and ensure the provision of high-quality KT care globally.
Article
Endocrinology & Metabolism
Dennis B. Campbell, David J. T. Campbell, Flora Au, Reed F. Beall, Paul E. Ronksley, Derek S. Chew, Yewande Ogundeji, Braden J. Manns, Brenda R. Hemmelgarn, Marcello Tonelli, Amity E. Quinn
Summary: This study aimed to describe the patterns and patient-level factors associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT2is) among adults with diabetes in Alberta, Canada. The use of SGLT2is is increasing among patients with diabetes, but remains low even in those with cardiovascular disease (CVD). Patient characteristics associated with lower odds of filling an SGLT2i prescription included female sex, older age, and lower income.
CANADIAN JOURNAL OF DIABETES
(2023)
Letter
Urology & Nephrology
Juergen Floege, Keisha L. Gibson, Manuel Praga, Jai Radhakrishnan, Heather N. Reich, Michiel F. Schreuder, Jack F. Wetzels, Vladimir Tesar, Marina Vivarelli, Steffen Biechele, Marcello Tonelli
KIDNEY INTERNATIONAL REPORTS
(2022)
Article
Medicine, General & Internal
Sankar D. Navaneethan, Sophia Zoungas, M. Luiza Caramori, Juliana C. N. Chan, Hiddo J. L. Heerspink, Clint Hurst, Adrian Liew, Erin D. Michos, Wasiu A. Olowu, Tami Sadusky, Nikhil Tandon, Katherine R. Tuttle, Christoph Wanner, Katy G. Wilkens, Jonathan C. Craig, David J. Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H. de Boer, Kamlesh Khunti
Summary: The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease is an update of the 2020 guideline. The guideline was updated based on reviewing new evidence and using the GRADE approach to assess evidence and develop consensus practice points. The recommendations were updated in the areas of comprehensive care and glucose-lowering therapies, while recommendations in the areas of glycemic monitoring, lifestyle interventions, and management approaches remained unchanged.
ANNALS OF INTERNAL MEDICINE
(2023)
Review
Health Policy & Services
K. J. Mrklas, J. M. Boyd, S. Shergill, S. Merali, M. Khan, L. Nowell, A. Goertzen, L. M. Pfadenhauer, K. Paul, K. M. Sibley, L. Swain, M. Vis-Dunbar, M. D. Hill, S. Raffin-Bouchal, M. Tonelli, I. D. Graham
Summary: The objective of this study was to identify and assess valid, reliable, and acceptable tools for evaluating outcomes and impacts of health research partnerships worldwide. A total of 48 studies and 58 tools were analyzed, with most tools consisting of surveys, questionnaires, and scales. While many tools had empirical validity, there were inconsistencies in the assessment and reporting of psychometric characteristics. The study also identified a subset of tools with empirical evidence, pragmatic strength, and moderate study quality.
HEALTH RESEARCH POLICY AND SYSTEMS
(2023)
Article
Urology & Nephrology
Thomas Hyunwoo Cho, Patrick C. K. Ng, Melissa J. Lefebvre, Arlene Desjarlais, Dennis McCann, Blair Waldvogel, Marcello Tonelli, Amit X. Garg, JoAnne Wilson, Monica Beaulieu, Judith Marin, Cali Orsulak, Melanie Talson, Monica Sharma, Jordanne Feldberg, Clara Bohm, Marisa Battistella
Summary: To reduce polypharmacy in hemodialysis patients, medication-specific patient education tools were developed and validated. These tools are crucial for patient participation in medication decision-making.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE
(2023)
Article
Urology & Nephrology
Rachel A. Lewis, Clara Bohm, Francis Fraser, Robert Fraser, Lee Woytkiw, Sylvia Jurgutis, Melissa Rubin, Gordon Smith, Jeann Buenafe, Nancy Verdin, James Hutton, Marcello Tonelli
Summary: Suboptimal transportation arrangements for in-center hemodialysis patients in Canada have been associated with stress, anxiety, reduced quality of life, and increased mortality risk. This study aimed to identify transportation options for these patients and describe stakeholder experiences.
Article
Cardiac & Cardiovascular Systems
David J. T. Campbell, Chad Mitchell, Brenda Hemmelgarn, Marcello Tonelli, Peter Faris, Jianguo Zhang, Ross T. Tsuyuki, Jane Fletcher, Flora Au, Scott Klarenbach, Derek Exner, Braden J. Manns
Summary: This study tested whether providing free high-value medications to low-income older adults at high cardiovascular risk would improve clinical outcomes. However, the results showed that although medication adherence improved, providing free medications did not improve clinical outcomes or reduce healthcare costs.
Article
Cardiac & Cardiovascular Systems
David J. T. Campbell, Marcello R. Tonelli, Brenda Hemmelgarn, Peter Faris, Jianguo Zhang, Flora T. Au, Ross Tsuyuki, Chad Mitchell, Raj Pannu, Tavis Campbell, Noah Ivers, Jane V. Fletcher, Derek J. Exner, Braden Manns
Summary: In a randomized trial conducted in Alberta, Canada, a tailored self-management education and support (SMES) program designed using advertising principles was found to reduce the rate of clinical outcomes among low-income older adults. The intervention included health promotion messaging and relay of clinical information to patients' healthcare providers. The study showed that the rate of the primary outcome, including death, myocardial infarction, stroke, coronary revascularization, and hospitalizations for cardiovascular-related conditions, was lower in the SMES group compared to the control group.
Article
Public, Environmental & Occupational Health
Ahmad Hecham Alani, Laura Miller, Isaac Waweru, Aston B. Atwiine, Stella Njagi, Marcello Tonelli, Kelly Kisarach, Abdelrhman Mohammed, Ronald Mugera, Nazik Mohamed Ibrahim, Dina Abdulhammed Mohamad, Lilian Kiapi
Summary: Non-communicable diseases (NCDs) pose a significant global health challenge, especially in humanitarian contexts with limited healthcare resources. The WHO Non-Communicable Diseases Kit (WHO-NCDK) is an intervention aimed at primary healthcare facilities in emergency situations, providing essential medicines and equipment for NCD management. An operational evaluation in Sudan found that the kit played a critical role in ensuring continuity of care during disruptions in the supply chain. However, contextual factors such as community familiarity with healthcare facilities, integration of NCDs into primary healthcare, and monitoring and evaluation systems were identified as important considerations for enhancing the kit's utility.
Review
Urology & Nephrology
Tyrone G. Harrison, Marcello Tonelli
Summary: The measurement of proteinuria is crucial for diagnosing and monitoring kidney disease, but there is still controversy and uncertainty surrounding the optimal measurement method. International guidelines recommend the use of urinary albumin-to-creatinine ratio, but this method is not universally available and can be costly. Additionally, the accuracy of different measurement methods may vary depending on the magnitude of albuminuria, sex, and clinical contexts.
KIDNEY INTERNATIONAL
(2023)
Review
Urology & Nephrology
Mehmet Sukru Sever, Valerie Luyckx, Marcello Tonelli, Rumeyza Kazancioglu, Darlene Rodgers, Dani Gallego, Serhan Tuglular, Raymond Vanholder
Summary: Patients with kidney disease are more vulnerable to the adverse effects of disasters due to their reliance on infrastructure, technology, drugs, and medical personnel. Pre-disaster preparedness, training, and emergency responses can help mitigate risks and improve outcomes for these patients.
NATURE REVIEWS NEPHROLOGY
(2023)
Article
Medicine, General & Internal
Marcello Tonelli, Natasha Wiebe, Meg Lunney, Maoliosa Donald, Tanis Howarth, Julie Evans, Scott W. Klarenbach, David Nicholas, Tiffany Boulton, Stephanie Thompson, Kara Schick Makaroff, Braden Manns, Brenda Hemmelgarn
Summary: Hearing loss is a common disability worldwide and is associated with a wide range of adverse clinical outcomes. This population-based cohort study in Alberta, Canada, found that individuals with hearing loss had higher rates of hospitalization, falls, adverse drug events, and emergency visits compared to those without hearing loss. They also had increased risks of death, cardiovascular events, depression, dementia, and other health issues.
Review
Medicine, General & Internal
Edmund Y. M. Chung, Suetonia C. Palmer, Valeria M. Saglimbene, Jonathan C. Craig, Marcello Tonelli, Giovanni F. M. Strippoli
Summary: This update of the Cochrane review found that erythropoiesis-stimulating agents (ESAs) may be more effective than placebo in treating anaemia in patients with chronic kidney disease, but their use may also increase the risk of cardiovascular events and hypertension. The comparative effects of different ESAs and their effects on other outcomes such as cardiovascular death and kidney failure remain uncertain.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(2023)
Review
Urology & Nephrology
Andrea C. Cowan, Kristin K. Clemens, Jessica M. Sontrop, Stephanie N. Dixon, Lauren Killin, Sierra Anderson, Rey R. Acedillo, Amit Bagga, Clara Bohm, Pierre Antoine Brown, Brenden Cote, Varun Dev, Claire Harris, Swapnil Hiremath, Mercedeh Kiaii, Eduardo Lacson Jr, Amber O. Molnar, Matthew J. Oliver, Malvinder S. Parmar, Jennifer M. McRae, Bharat Nathoo, Kathleen Quinn, Nikhil Shah, Samuel A. Silver, Daniel J. Tascona, Stephanie Thompson, Robert H. Ting, Marcello Tonelli, Hans Vorster, Davinder B. Wadehra, Ron Wald, Myles Wolf, Amit X. Garg
Summary: This review examines the impact of magnesium intake on bone metabolism and fracture risk, revealing that sufficient magnesium intake can improve bone density and reduce fracture risk in individuals with normal kidney function. However, the relationship between magnesium concentration and bone-related outcomes in patients receiving dialysis is still poorly understood.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE
(2023)